William Mallender

Company: Tango Therapeutics Sub, Inc - dba Tango Therapeutics

Job title: Senior Vice President - Biochemistry

Seminars:

Incorporating Novelty and Diversity in Oncology Drug Discovery: From Cancer Genome Screening to Ligand Identification 10:45 am

• Focusing on unique, ‘yet to be drugged’ cancer targets • Enabling novel targets for screening campaigns to interrogate ligandability • Evaluating hits identified from orthogonal screening methodsRead more

day: Day Two